European regulators find no evidence of link between new obesity medicines and suicidal thoughts
Stat
Fri, 04/12/24 - 11:09 am
Novo Nordisk
Ozempic
Wegovy
EMA
obesity
weight loss
suicide
EU approves Illumina's plan to divest cancer test maker Grail
Reuters
Fri, 04/12/24 - 11:08 am
Europe
Illumina
Grail
M&A
diagnostics
Medtech
Bayer's patent for blood thinner Xarelto invalid, UK court rules
Reuters
Fri, 04/12/24 - 11:06 am
Bayer
UK
patents
bloodthinners
Xarelto
What about the company Vertex didn’t buy?
Stat
Fri, 04/12/24 - 11:05 am
Vertex Pharmaceuticals
M&A
Alpine Immune Sciences
Vera Therapeutics
IgA nephropathy
A doctor's bullish case for AI, co-written by AI
Axios
Fri, 04/12/24 - 11:03 am
artificial intelligence
NVIDIA
Kaiser Permanente
BioMarin’s Voxzogo shows promise in hypochondroplasia
Pharmaphorum
Fri, 04/12/24 - 11:02 am
Biomarin
Voxzogo
hypochondroplasia
Shareholders approve AstraZeneca's 2024 pay proposal for CEO Pascal Soriot despite proxy adviser discontent
Fierce Pharma
Fri, 04/12/24 - 11:01 am
AstraZeneca
Pascal Soriot
Pharma CEOs
executive compensation
Allay’s ATX101 offers post-surgical pain relief in Phase IIB trial
Clinical Trials Arena
Fri, 04/12/24 - 11:00 am
Allay Therapeutics
clinical trials
post-surgical pain
ATX-101
Biopharma Layoff Tracker 2024: Genentech, Sanofi, Novartis and More Cut Staff
BioSpace
Thu, 04/11/24 - 10:22 pm
biotech
layoffs
Genentech
Sanofi
Novartis
Publicis jumps 5.3% in Q1 driven by ‘new business tailwinds’
Medical Marketing and Media
Thu, 04/11/24 - 10:17 pm
Publicis
earnings
AbbVie-backed effort spotlights night symptoms of Parkinson’s
Medical Marketing and Media
Thu, 04/11/24 - 10:15 pm
Parkinson's Disease
AbbVie
public awareness
Fujifilm Diosynth blueprints another $1.2B expansion at North Carolina plant where it aims to employ 1,400
Fierce Pharma
Thu, 04/11/24 - 10:13 pm
Fujifilm Diosynth Biotechnologies
North Carolina
drug manufacturing
Moderna Halts Plans for Kenyan mRNA Vaccine Plant After Taking $1B Financial Hit
BioSpace
Thu, 04/11/24 - 10:12 pm
Moderna Therapeutics
MRNA
drug manufacturing
vaccines
Kenya
April 11 2024 - Novartis pays $150M for Arvinas' phase 3-ready prostate cancer protein degrader
Thu, 04/11/24 - 12:00 pm
Novartis pays $150M for Arvinas' phase 3-ready prostate cancer protein degrader
Fierce Biotech
Thu, 04/11/24 - 11:56 am
Novartis
Arvinas
protein degradation
prostate cancer
Novartis begins tender offer for cancer-focused MorphoSys
Reuters
Thu, 04/11/24 - 11:54 am
Novartis
M&A
cancer
MorphoSys
Telehealth clinical trial cuts hospital cardiac readmissions by 76%
Clinical Trials Arena
Thu, 04/11/24 - 11:48 am
SHL Telemedicine
telehealth
SmartHeart
acute coronary syndrome
Gas prices are hurting biotech
Stat
Thu, 04/11/24 - 11:45 am
gas prices
biotech
inflation
Teva’s Ajovy hits endpoint in Chinese Phase III trial for migraine prevention
Clinical Trials Arena
Thu, 04/11/24 - 11:43 am
Teva Pharmaceutical
clinical trials
Ajovy
migraines
China
Pfizer settles 12-year-old lawsuit in alleged pay-for-delay scheme for $39M
Fierce Pharma
Thu, 04/11/24 - 11:31 am
Pfizer
legal
Wyeth
M&A
pay-for-delay
antitrust

Pages